8-K: Safety Shot Inc. Serves Notice of Lawsuit via Public Disclosure After Defendants Attempt to Evade Service
Litigation Update
Safety Shot Inc. has been authorized by a court order to serve notice of a lawsuit against Capybara Research and Igor Appelboom through a public disclosure and press release after the defendants attempted to evade traditional service methods.
Summary
- Safety Shot, Inc. filed a lawsuit against Capybara Research and Igor Appelboom for allegedly publishing defamatory articles to manipulate the company's stock price.
- The company alleges that Capybara Research and Igor Appelboom took short positions in Safety Shot and then released negative reports to drive down the stock price for their own financial gain.
- After initial attempts to serve the defendants by email failed due to their evasive actions, the court granted Safety Shot permission to serve notice through a press release and SEC filing.
- This method of service is considered a historic, first-of-its-kind order by the court.
- The lawsuit was filed after a defamatory article published on November 22, 2023, led to a 37.03% decline in Safety Shot's share price.
Sentiment
Score: 3
Explanation: The document highlights a significant negative event (share price drop) and legal challenges, indicating a negative sentiment despite the company's efforts to address the situation.
Positives
- The court granted Safety Shot's motion for alternative service, allowing them to proceed with the lawsuit despite the defendants' attempts to evade service.
- The company is actively pursuing legal action to protect its shareholders from alleged market manipulation.
- The company is taking a strong stance against what it believes is criminal behavior.
Negatives
- The company's share price experienced a significant 37.03% decline following the publication of a defamatory article.
- The defendants have actively tried to evade service, indicating a potential lack of cooperation.
- The company had to seek a second motion for alternative service due to the defendants' evasive actions.
Risks
- The lawsuit may be costly and time-consuming, with no guarantee of a favorable outcome.
- The negative publicity surrounding the lawsuit could further impact the company's stock price.
- The defendants' evasive actions may indicate a lack of willingness to engage in a fair legal process.
Future Outlook
Safety Shot plans to launch business-to-business sales of Safety Shot in the first quarter of 2024 and spin off legacy assets from its Jupiter Wellness business.
Management Comments
- The Company believes this is criminal behavior and will continue to do what it can to protect the interests of its shareholders.
Industry Context
This announcement highlights the risks associated with short selling and the potential for market manipulation through the dissemination of false information. It also underscores the challenges companies face in pursuing legal action against anonymous or evasive actors.
Comparison to Industry Standards
- The use of public disclosure to serve notice of a lawsuit is highly unusual and indicates the extreme measures the company had to take due to the defendants' evasive actions.
- The 37.03% share price decline is a significant impact, highlighting the potential damage that can be caused by defamatory articles.
- The case is unique in that it involves a court order to serve notice via public disclosure, which is not a standard practice in litigation.
Legal Proceedings
- Safety Shot, Inc. has filed a lawsuit against Capybara Research and Igor Appelboom for alleged defamation and market manipulation.
- The court has granted Safety Shot permission to serve notice of the lawsuit through a press release and SEC filing.
Stakeholder Impact
- Shareholders have been negatively impacted by the 37.03% decline in share price.
- The company is taking legal action to protect shareholder interests.
- The lawsuit may have a negative impact on the company's reputation.
Next Steps
- Safety Shot will continue to pursue legal action against Capybara Research and Igor Appelboom.
- The company plans to launch business-to-business sales of Safety Shot in the first quarter of 2024.
- Safety Shot plans to spin off legacy assets from its Jupiter Wellness business.
Key Dates
| Date | Description |
|---|---|
| 2023-11-22 | Date of the defamatory article that led to a 37.03% decline in Safety Shot's share price. |
| 2023-12-05 | Safety Shot announced that it filed a federal lawsuit against Capybara Research and Igor Appelboom. |
| 2023-12-22 | Safety Shot filed a motion to alternatively serve the summons and complaint by email. |
| 2023-12-26 | The court granted Safety Shot's motion to serve the defendants by email. |
| 2024-01-08 | Safety Shot filed a second motion for alternative service due to the defendants' evasive actions. |
| 2024-01-10 | The court granted Safety Shot's second motion, allowing service through public disclosure. |
| 2024-01-16 | Date of the press release and 8-K filing serving notice of the lawsuit. |
Keywords
lawsuit, defamation, market manipulation, short selling, alternative service, Capybara Research, Igor Appelboom, share price, legal action, evasion
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.